View all cases
UPC CFI 106/2026
Jan 12, 2026·EP2493466 · NOVEL ANTITUMORAL USE OF CABAZITAXEL
- Case details
- StatusCase ClosedActionOtherCategoryOther procedural
- Parties
- Claimants
- Sanofi Mature IPOperating co.
- Sanofi Winthrop IndustrieOperating co.
- Sanofi-Aventis FranceOperating co.
- Sanofi-Aventis GmbHOperating co.
- Sanofi BelgiumOperating co.
- Sanofi-Aventis Deutschland GmbHOperating co.
- Sanofi S.r.l.Operating co.
- Sanofi B.V.Operating co.
- Sanofi - Produtos Farmaceuticos LdaOperating co.
- Sanofi ABOperating co.
- Sanofi A/SOperating co.
Representatives- Frédéric Chevallier-McDermott Will & Schulte
- Agathe Michel-De Cazotte-Carpmaels & Ransford
Respondents- STADAPHARM GmbHOperating co.
- STADA Arzneimittel AGOperating co.
- STADA Nordic ApSOperating co.
Representatives- Konstantin Schallmoser-Bonabry
- Division
- Munich LD
- Technology
- ChemistryPharmaceuticals
- Language
- English
- EPO Opposition
- Glenmark Pharmaceuticals Europe Ltd2021-03-10
- Accord Healthcare LtdAdmissible2021-03-10
- Teva Pharmaceutical Industries Ltd.Admissible2021-03-10
- EVER Valinject GmbHWithdrawn2021-03-12
- Zentiva k.s.Admissible2021-03-12
- medac Gesellschaft für klinische Spezialpräparate mbHWithdrawn2021-03-22
- Fresenius Kabi Deutschland GmbHAdmissible2021-03-23
- Dr. Reddy's Laboratories Ltd.Admissible2021-03-31
- Betapharm Arzneimittel GmbHAdmissible2021-03-31
- Generics (U.K.) LimitedAdmissible2021-06-08
- Vossius & Partner Patentanwälte Rechtsanwälte mbBAdmissible2021-12-03
- STADA Arzneimittel AGAdmissible2021-12-09
- Maiwald GmbHAdmissible2021-12-10
- Accord Healthcare S.L.U.2024-08-30
How this compares
How long the court takes to reach a first decision.
| Median days to first decision | |
|---|---|
| All UPC | 124 |
| Munich LD | Locked |
| Judge Matthias Zigann | Locked |
| Judge Tobias Pichlmaier | Locked |
| Judge Alima Zana | Locked |
At the UPC: Sanofi Group (33 cases)·STADAPHARM GmbH (10 cases)
Start 14-day free trialAlready a user? Sign in
Related cases
All proceedings on this patentThis dispute contains 10 other proceedings
UPC CoA 22/2026·UPC CoA 25/2026·UPC CFI 108/2026·UPC CFI 496/2024·UPC CFI 146/2024 and 5 more
10 other defendants litigating the same or a related patent
UPC CoA 23/2026·UPC CoA 24/2026·UPC CoA 26/2026·UPC CoA 27/2026·UPC CFI 503/2024 and 5 more
Decisions
- —other
Summary: I. The Claimants must reimburse the Defendants the total amount of EUR 1,082,680.70 as recoverable costs of the first instance proceedings in accordance with the agreement between the parties, including timing of said reimbursement. II. The amount provided in I. shall be reimbursed to the Claimants if the Court of Appeal sets aside the first instance decision. III. The costs proceedings are closed.
Documents
| Document title | Date | Public |
|---|---|---|
| Publication | 2026-02-23 | Not public |
| Case closed | 2026-02-13 | Not public |
| Decision | 2026-02-13 | Not public |
| Decision | 2026-02-13 | Public |
| Receipt | 2026-02-09 | Not public |
| Cover sheet | 2026-02-09 | Not public |
| Document | 2026-02-09 | Not public |
| Communication | 2026-02-03 | Not public |
| Receipt | 2026-02-02 | Not public |
| Cover sheet | 2026-02-02 | Not public |
| Other document Respondent | 2026-02-02 | Not public |
| Communication | 2026-01-16 | Not public |
| Receipt | 2026-01-12 | Not public |
| Cover sheet | 2026-01-12 | Not public |
| Exhibit document Applicant | 2026-01-12 | Not public |
| Exhibit document Applicant | 2026-01-12 | Not public |
| Exhibit document Applicant | 2026-01-12 | Not public |
| Exhibit document Applicant | 2026-01-12 | Not public |
| Application document Applicant | 2026-01-12 | Not public |